BCHE and Alzheimer disease: Other multitarget-directed ligands have been tested in the context of AD, such as BIGI-3h, a compound that exhibits inhibitory activity against cholinesterase, MAO, GSK-3β, and calcium-channel-blockade activity through the inhibition of VGCC.